Cryoablation of bone metastases in thyroid and adrenocortical cancers

Cryoablation led to a sustained reduction in pain with a mean improvement of 7.2 points on a 1-10 scale of the Brief Pain Inventory - Short Form (BPI-SF) after 54 weeks. Pain relief and quality-of-life improvement (assessed by the BPI-SF) were observed in 81.3% of bone metastases just one week after cryoablation with an overall pain score reduction of 4.8 points. Cryoablation of bone metastases from endocrine cancers was safe and effective, providing long-lasting pain relief.